VIR

Vir Biotechnology Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Momentum↑ 7/10
Vir Biotechnology sales and earnings growth
VIR Growth
Good
  • Revenue Y/Y↓ -7.61%
  • EPS Y/Y↑ 17.49%
  • FCF Y/Y↑ 11.97%
Vir Biotechnology gross and profit margin trends
VIR Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -638.90%
  • ROIC↓ -53.00%
Vir Biotechnology net debt vs free cash flow
VIR Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vir Biotechnology stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗